Back to Directory Katherine Luzuriaga Email katherine.luzuriaga@umassmed.edu Institution Division of Pediatric Immunology, Infectious Diseases, and Rheumatology Title Professor and Chief Request an Update Affiliated Studies IMPAACT 2052: Safety and pharmacokinetics of an AAV-Vectored broadly neutralizing antibody in infants living with HIV DAIDS Number 39268 Research Area Cure and Immunotherapy Study Status In Development P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study DAIDS Number 11954 Research Area Cure and Immunotherapy Study Status Enrolling P1007: Phase I Salvage Therapy DAIDS Number 10315 Research Area Other Study Status Concluded P1017: PEG-Intron in HIV+Children DAIDS Number 10317 Research Area Other Study Status Concluded P1030: Lopinavir/Ritonavir in HIV-1 Infected Infants DAIDS Number 10041 Research Area Other Study Status Concluded Show All
IMPAACT 2052: Safety and pharmacokinetics of an AAV-Vectored broadly neutralizing antibody in infants living with HIV DAIDS Number 39268 Research Area Cure and Immunotherapy Study Status In Development
P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study DAIDS Number 11954 Research Area Cure and Immunotherapy Study Status Enrolling
P1030: Lopinavir/Ritonavir in HIV-1 Infected Infants DAIDS Number 10041 Research Area Other Study Status Concluded
